Articles by Dr. Priya Sharma
Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies
Cryoport reports 26% revenue growth in Q1 2026, supporting a record 766 global clinical trials and 21 commercially approved cell and gene therapies worldwide.
Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling
Planned Parenthood can continue dispensing Mifepristone by mail and certified pharmacies until May 11 following Supreme Court provisional hold on 5th Circuit ruling.
Arrowhead Pharmaceuticals Receives TGA Approval for REDEMPLO (Plozasiran) in Australia for Rare Genetic Disorder
Arrowhead Pharmaceuticals gains Australian TGA approval for REDEMPLO (plozasiran), expanding global access for familial chylomicronemia syndrome patients.
Amgen Reports Strong Q1 2026 Financial Results with 16 Brands Achieving Double-Digit Growth
Amgen's Q1 2026 results show robust performance with 16 brands posting double-digit growth, offsetting patent expirations and increased competition.
Haier Biomedical Reports Record 36% International Revenue Growth in Life Science Infrastructure Market
Haier Biomedical achieves 36% international revenue share with $340.77M total revenue, driving AI-powered life science infrastructure expansion globally.
Prolacta's Human Milk-Based Fortifiers Receive World's First Prescription Drug Status in Japan Following JASMINE Trial Success
Prolacta achieves global regulatory milestone as Japan grants prescription drug status to human milk-based fortifiers for premature infants based on JASMINE trial data.
Vivacta Bio Raises $50M+ Series A Funding for GT801 CAR-T Gene Therapy Development
Vivacta Biotechnology closes $50M+ Series A funding to advance GT801, an innovative in vivo CAR-T therapy for blood cancers and autoimmune diseases.
Energenesis Biomedical ENERGI-F703DFU Diabetic Foot Ulcer Treatment Data to Be Presented at EWMA 2026
Energenesis Biomedical will present clinical data for ENERGI-F703DFU gel, a novel topical treatment for diabetic foot ulcers, at EWMA 2026 in Bremen.
KRAS G12C Inhibitors NSCLC: Market Analysis of Sotorasib & Adagrasib
This article delves into the market dynamics of KRAS G12C inhibitors, Sotorasib and Adagrasib, highlighting their roles in non-small cell lung cancer treatment.
Thailand Emerges as ASEAN Medical Device Gateway as Market Set to Reach $18.6B by 2029
Thailand positions itself as Southeast Asia's medical device hub with WHX Bangkok 2026, targeting $18.6B regional MedTech market growing at 7.31% annually.
Patient Diversity in MEA Clinical Trials: Strategies for Inclusive Recruitment
This article discusses the importance of patient diversity in MEA clinical trials and outlines strategies to enhance inclusive recruitment for better drug efficacy.
SAHPRA Biosimilars Approval: Pathway Analysis & Access Impact
This article analyzes SAHPRA's biosimilars approval pathway and its significant impact on improving access to vital treatments, including adalimumab.
Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business
Zhengye Biotechnology (NASDAQ: ZYBT) announces fiscal year 2025 financial results, highlighting performance in veterinary vaccine manufacturing and research operations.
Testosterone Therapy FDA Update: Key Regulatory Advances
The FDA has announced important regulatory advancements on testosterone therapy for men, focusing on improved safety monitoring and updated approval processes. Learn what this means for testosterone deficiency treatment.
Eyebright Medical Reports Strong 2025 Results Driven by Innovation and Global Expansion
Eyebright Medical Technology releases 2025 annual and sustainability reports showing strong performance amid industry policy adjustments and global expansion.
SAKIGAKE Designation Impact: Accelerating Rare Disease Drug Approvals in Japan
The SAKIGAKE Designation significantly speeds up the approval process for rare disease drugs in Japan, enhancing access to treatments like XYZ for patients with ABC condition.
Transcarent Partners with SmithRx to Expand Pharmacy Benefits Platform for Lower Drug Costs
Transcarent integrates SmithRx into its WayFinding platform to provide employers with enhanced pharmacy pricing transparency and reduced prescription drug costs.
HanchorBio Partners with Bloomberg to Enhance Drug Development Intelligence and Biopharma Strategy
HanchorBio selects Bloomberg's strategic intelligence platform to strengthen its immunotherapy drug development and global biopharma operations.
ANVISA Approves Emtricitabine-Tenofovir Combo: Market Impact in Brazil
The recent ANVISA approval of the Emtricitabine-Tenofovir combination for HIV treatment is set to transform the Brazilian pharmaceutical market.
RFID Technology Market to Reach $15 Billion by 2032, Transforming Pharmaceutical Supply Chain Management
RFID tags market projected to hit $15 billion by 2032, driven by pharmaceutical serialization mandates and IoT integration for enhanced drug tracking.